GO:0004906 type II interferon receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004906 (type II interferon receptor activity) is the molecular function of binding interferon-gamma (IFN-gamma) and transmitting the signal across the membrane to initiate a cellular response.
• The receptor is a heterodimer of IFNGR1 and IFNGR2, which activates JAK1/JAK2 and STAT1 to drive IFN-gamma-inducible gene expression.
• Type II interferon receptor activity is distinct from type I and type III interferon receptor activities, with different ligand specificity and downstream effects.
• Dysregulation of this activity is implicated in infectious diseases, autoimmune conditions, and cancer, including Chlamydia trachomatis infection and acute myeloid leukemia.
• Viral proteins and host kinases can modulate receptor stability; for example, influenza hemagglutinin and casein kinase 1 alpha promote degradation of type I and type II interferon receptors.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of IFNGR1, IFNGR2, and signaling components in disease.
Description
Type II interferon receptor activity (GO:0004906) is a molecular function defined as the ability to combine with interferon-gamma (IFN-gamma) and transmit a signal from one side of the membrane to the other, initiating a change in cell activity. This activity is mediated by the heterodimeric receptor composed of IFNGR1 and IFNGR2, which is expressed on the surface of most nucleated cells. Unlike type I interferon receptors that bind IFN-alpha/beta, the type II receptor specifically recognizes IFN-gamma, a cytokine critical for innate and adaptive immunity against viral and intracellular bacterial infections. The functional importance of this receptor is underscored by studies showing that type I, but not type II, interferon receptor knockout mice are susceptible to biliary atresia, highlighting non-redundant roles. In cancer, intra-leukemic interferon signaling through this receptor can suppress expansion and mediate chemoresistance in acute myeloid leukemia. Thus, understanding the molecular mechanisms, regulatory control, and disease associations of type II interferon receptor activity is essential for immunology and therapeutic development.
type II interferon receptor activity At A Glance
| GO ID | GO:0004906 |
|---|---|
| GO term | type II interferon receptor activity |
| Ontology | molecular_function |
| Synonym | IFN-gamma receptor activity, IFNG receptor activity, interferon-gamma receptor activity |
| Definition | Combining with interferon-gamma (a type II interferon) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Binding IFN-gamma and initiating JAK-STAT signaling |
| Major ligands | Interferon-gamma (IFN-gamma) |
| Major subunits | IFNGR1, IFNGR2 |
| Downstream effectors | JAK1, JAK2, STAT1 |
What Is GO:0004906?
In our own words, type II interferon receptor activity (GO:0004906) is the function of a cell-surface receptor complex that specifically binds interferon-gamma and converts this binding event into an intracellular signal, thereby altering gene expression and cellular behavior. This activity requires the coordinated action of two subunits, IFNGR1 and IFNGR2, and associated kinases.
Why Is type II interferon receptor activity Important in Cell Biology?
Type II interferon receptor activity is central to host defense against pathogens and to immune regulation. It mediates the biological effects of IFN-gamma, a cytokine that activates macrophages, enhances antigen presentation, and coordinates innate and adaptive immunity. Defects in this receptor or its signaling pathway lead to increased susceptibility to mycobacterial and viral infections. Moreover, this activity is implicated in autoimmune diseases, cancer immunosurveillance, and inflammatory disorders, making it a target for therapeutic intervention.
• Essential for IFN-gamma-mediated immune responses against intracellular pathogens.
• Distinct from type I and type III interferon receptor activities, allowing specific targeting.
• Plays a role in biliary atresia susceptibility, as type I but not type II receptor knockout mice are susceptible.
• Modulates leukemia cell expansion and chemoresistance in acute myeloid leukemia.
• Regulated by acetylation-dependent signal transduction mechanisms.
• Influenced by mRNA translation regulation of interferon-dependent genes.
• Targeted by viral proteins such as influenza hemagglutinin for degradation.
• Associated with autoimmune conditions like murine lupus, where type I IFN protects.
• Key for controlling Chlamydia trachomatis infection in the female genital tract.
• Provides a model for studying receptor trafficking and signal transduction.
Molecular Mechanism of type II interferon receptor activity
Ligand Binding and Receptor Dimerization
In simple terms: IFN-gamma binds to the receptor, causing two receptor parts to come together.
Type II interferon receptor activity begins with the specific binding of IFN-gamma to the extracellular domain of IFNGR1, which then recruits IFNGR2 to form a functional heterodimeric complex. This dimerization is essential for transmitting the signal across the membrane.
JAK-STAT Activation
In simple terms: The receptor activates JAK kinases, which then turn on STAT1 to change gene expression.
Upon dimerization, the receptor-associated kinases JAK1 and JAK2 are activated and phosphorylate tyrosine residues on the intracellular domain of IFNGR1, creating docking sites for STAT1. STAT1 is then phosphorylated, dimerizes, and translocates to the nucleus to drive transcription of IFN-gamma-inducible genes.
Regulation by Acetylation
In simple terms: Chemical tags on the receptor can control how signals are sent.
Acetylation-dependent signal transduction has been described for type I interferon receptor, and similar regulatory mechanisms may influence type II receptor activity. This adds a layer of control beyond phosphorylation.
Receptor Degradation and Turnover
In simple terms: Receptors can be broken down by viral or host factors, limiting signaling.
Casein kinase 1 alpha mediates the degradation of receptors for type I and type II interferons caused by influenza A virus hemagglutinin, thereby modulating the duration and intensity of signaling. This regulation is critical for balancing antiviral responses.
Cross-talk with mRNA Translation
In simple terms: Interferon signaling also affects how proteins are made from mRNA.
Interferon-dependent mRNA translation of target genes is regulated, impacting the overall cellular response to IFN-gamma. This translational control fine-tunes the expression of effector proteins.
Key Genes Involved in GO:0004906 type II interferon receptor activity
The following genes encode the core components and regulators of type II interferon receptor activity and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IFNGR1 | Ligand-binding subunit of the type II interferon receptor | Knockout models show loss of IFN-gamma responsiveness |
| IFNGR2 | Signal-transducing subunit of the receptor | Essential for JAK-STAT activation |
| JAK1 | Janus kinase associated with IFNGR1 | Phosphorylates STAT1 |
| JAK2 | Janus kinase associated with IFNGR2 | Phosphorylates STAT1 |
| STAT1 | Transcription factor downstream of receptor | Mediates IFN-gamma-inducible gene expression |
| CSNK1A1 | Casein kinase 1 alpha | Mediates degradation of type I and II interferon receptors |
| IFNG | Interferon-gamma ligand | Binds and activates the receptor |
| IRF1 | Interferon regulatory factor 1 | Transcription factor induced by IFN-gamma signaling |
| SOCS1 | Suppressor of cytokine signaling 1 | Negative regulator of JAK-STAT pathway |
| PIAS1 | Protein inhibitor of activated STAT1 | Inhibits STAT1 DNA binding |
| PTPN2 | Protein tyrosine phosphatase non-receptor type 2 | Dephosphorylates JAKs and STAT1 |
| NMI | N-myc and STAT interactor | Modulates STAT1 activity |
| GBP1 | Guanylate binding protein 1 | IFN-gamma-inducible effector |
| IRF8 | Interferon regulatory factor 8 | Regulates IFN-gamma-inducible genes |
| CIITA | Class II major histocompatibility complex transactivator | Induced by IFN-gamma, controls antigen presentation |
| CXCL10 | C-X-C motif chemokine ligand 10 | IFN-gamma-inducible chemokine |
| NOS2 | Nitric oxide synthase 2 | IFN-gamma-inducible enzyme in macrophages |
How Is type II interferon receptor activity Regulated?
Type II interferon receptor activity is regulated at multiple levels. Receptor expression and stability are controlled by kinases such as casein kinase 1 alpha, which mediates degradation in response to viral proteins. Acetylation-dependent signal transduction provides another regulatory layer. Additionally, interferon-dependent mRNA translation of target genes modulates the downstream response. Negative feedback loops involving SOCS1 and phosphatases like PTPN2 attenuate signaling.
type II interferon receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IFNGR1 | Biliary atresia susceptibility | Knockout mouse |
| IFNGR1/IFNGR2 | Chlamydia trachomatis infection | Knockout mouse |
| IFNGR1/IFNGR2 | Acute myeloid leukemia | Knockout human cell lines |
| IFNGR1 | Murine lupus | Knockout mouse |
| CSNK1A1 | Influenza A virus immune evasion | Knockout cell lines |
Infectious Diseases
Type II interferon receptor activity is critical for controlling intracellular pathogens. In a mouse model, type I but not type II interferon receptor knockout mice are susceptible to biliary atresia, suggesting a specific role for type II signaling in this context. Regulation of Chlamydia trachomatis infection in the female genital tract by type I and type II interferons highlights the importance of this receptor in bacterial clearance. Additionally, type III interferon-mediated signaling is critical for controlling live attenuated yellow fever virus infection in vivo, indicating interplay among interferon types.
Cancer
Intra-leukemic interferon signaling through type II interferon receptor activity suppresses expansion and mediates chemoresistance in human acute myeloid leukemia. This suggests that modulating this receptor pathway could be therapeutically beneficial.
Autoimmune and Inflammatory Diseases
Type I IFN protects against murine lupus, but the role of type II interferon receptor activity in autoimmunity is complex. Dysregulated IFN-gamma signaling has been implicated in various autoimmune conditions, and understanding the receptor's function may inform targeted therapies.
From type II interferon receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IFNGR1 abolish IFN-gamma signaling? | IFNGR1 knockout cell line or mouse |
| Can a point mutation in IFNGR1 affect ligand binding? | Point mutation knock-in |
| How does tagging IFNGR2 affect receptor trafficking? | Tagged knock-in |
| Does overexpression of IFNGR1 enhance sensitivity to IFN-gamma? | Overexpression cell line |
| What is the role of CSNK1A1 in receptor degradation? | CSNK1A1 knockout |
| Does STAT1 knockout block downstream gene expression? | STAT1 knockout |
How to Study the type II interferon receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify IFN-gamma-inducible genes |
| Phosphoproteomics | Phosphorylation of signaling proteins | Map JAK-STAT activation |
| Western blot | Protein levels and phosphorylation | Validate receptor degradation |
| Immunofluorescence | Subcellular localization | Track receptor internalization |
| CRISPR knockout | Loss-of-function phenotypes | Test gene necessity |
| CRISPR knock-in | Tagged or mutant protein expression | Study trafficking or point mutations |
| Overexpression | Gain-of-function effects | Enhance signaling |
| Flow cytometry | Cell surface receptor expression | Quantify IFNGR1/2 levels |
Transcriptomic Analysis
RNA-seq can measure IFN-gamma-inducible gene expression changes upon receptor activation or knockout, providing a global view of downstream effects.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry-based proteomics can identify phosphorylation events on JAKs and STATs following receptor stimulation, revealing signaling dynamics.
Imaging and Trafficking Studies
Fluorescence microscopy of tagged receptors can visualize internalization and degradation, as shown for influenza hemagglutinin-mediated degradation.
Functional Assays
Antiviral or antibacterial assays in knockout cells can assess the contribution of type II interferon receptor activity to pathogen control.
How CRISPR Can Be Used to Study GO:0004906 type II interferon receptor activity
Knockout
CRISPR knockout of IFNGR1 or IFNGR2 abolishes type II interferon receptor activity, allowing researchers to test its role in immune responses and disease models.
Point Mutation
Introducing point mutations in IFNGR1 or IFNGR2 can dissect ligand-binding or signaling domains, revealing critical residues for receptor function.
Knock-in
Knock-in of tagged receptors (e.g., GFP or HA) enables real-time imaging of receptor trafficking and degradation under physiological conditions.
Overexpression
Overexpression of IFNGR1 or IFNGR2 can sensitize cells to IFN-gamma, useful for studying enhanced signaling in cancer or inflammation.
How EDITGENE Supports type II interferon receptor activity Research
Researchers studying type II interferon receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for type II interferon receptor activity research.
Frequently Asked Questions About type II interferon receptor activity
What is type II interferon receptor activity?
It is the molecular function of binding interferon-gamma and transmitting a signal across the membrane to initiate cellular changes, encoded by GO:0004906.
What genes are involved in type II interferon receptor activity?
Key genes include IFNGR1, IFNGR2, JAK1, JAK2, and STAT1.
How does type II interferon receptor signaling work?
IFN-gamma binds IFNGR1, recruiting IFNGR2, which activates JAK kinases and STAT1 to induce gene expression.
What diseases are associated with type II interferon receptor activity?
It is linked to infectious diseases, cancer, and autoimmune conditions such as biliary atresia and acute myeloid leukemia.
How can I study type II interferon receptor activity using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of the receptor and its pathway.
What is the difference between type I and type II interferon receptors?
Type I receptors bind IFN-alpha/beta, while type II receptors bind IFN-gamma; they have distinct subunits and downstream effects.
Can type II interferon receptor activity be regulated?
Yes, it is regulated by acetylation, kinase-mediated degradation, and mRNA translation control.
What cell models are available for type II interferon receptor research?
Knockout mice, knockout cell lines, and tagged knock-in cells are commonly used.
Why is type II interferon receptor activity important in cancer?
It can suppress leukemia cell expansion and mediate chemoresistance, making it a potential therapeutic target.
How does influenza virus affect type II interferon receptor activity?
Influenza hemagglutinin and casein kinase 1 alpha promote degradation of type I and type II interferon receptors, aiding immune evasion.
Conclusion
Type II interferon receptor activity (GO:0004906) is a fundamental molecular function that mediates IFN-gamma signaling, with critical roles in immunity, infection, and cancer. Understanding its mechanisms and regulation provides insights into disease pathogenesis and therapeutic opportunities. CRISPR-based models are invaluable for dissecting this pathway and developing targeted interventions.
References
- 1. Kuebler JF et al.. 2006. Type-I but not type-II interferon receptor knockout mice are susceptible to biliary atresia.. Pediatr Res 59(6):790-4 PMID: 16641200
- 2. Karigane D et al.. 2026. Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML.. Blood Cancer Discov 7(1):68-84 PMID: 41165556
- 3. Tang X et al.. 2007. Acetylation-dependent signal transduction for type I interferon receptor.. Cell 131(1):93-105 PMID: 17923090
- 4. Kroczynska B et al.. 2014. Regulation of interferon-dependent mRNA translation of target genes.. J Interferon Cytokine Res 34(4):289-96 PMID: 24559173
- 5. Douam F et al.. 2017. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.. mBio 8(4) PMID: 28811340
- 6. He R et al.. 2026. Regulation of Chlamydia trachomatis infection in the female genital tract by type I and type II interferons.. bioRxiv PMID: 42538957
- 7. Xia C et al.. 2018. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.. J Virol 92(7) PMID: 29343571
- 8. Hron JD et al.. 2004. Type I IFN protects against murine lupus.. J Immunol 173(3):2134-42 PMID: 15265950
